Roth MKM raised the firm’s price target on Globus Medical (GMED) to $115 from $100 and keeps a Buy rating on the shares. The stock’s 2024 outperformance justified the firm’s “Top Pick” call for this ...
The average one-year price target for Globus Medical (NYSE:GMED) has been revised to $90.69 / share. This is an increase of 10.72% from the prior estimate of $81.91 dated November 7, 2025. The price ...
Merit Medical Systems (NASDAQ:MMSI – Free Report) had its price target lowered by Barrington Research from $115.00 to $111.00 in a research note issued to investors on Wednesday morning,Benzinga ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback